Answers are grounded in this paper and cite their sources.
Randomized crossover study shows oxytocin does not affect food intake or glucose in individuals with obesity, indicating limited appetite regulation potential.
In individuals with obesity, 4.5-hour intravenous infusion of oxytocin causing supraphysiological plasma concentrations of ~400 pg/mL has no effect on ad libitum food intake, appetite sensations, plasma glucose levels, circulating concentrations of glucose and appetite-regulating hormones, or gastric emptying.
No takes yet. Share an insight, caveat, or question.
Gether et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: